Nancy Whiting

Nancy Whiting holds extensive experience in the biotechnology and pharmaceutical industries. Currently, Nancy serves as a board member at Biocom California and Boundless Bio and as Chief Executive Officer at Recludix Pharma since September 2021. Nancy has also been a board member at Caribou Biosciences and previously held the position of Chief Executive Officer at Stealth Biotech. Prior to these roles, Nancy spent over 14 years at Seagen, where various leadership positions included Executive Vice President of Corporate Strategy, Alliances and Communications, and Executive Vice President, Head of Late Stage Development. Nancy's earlier experience includes a Senior Oncology Medical Scientist role at GSK and a Clinical Pharmacist position at the University of Washington. Academic credentials include a Pharm.D. from the University of Washington and a B.Sc.(Pharm) from The University of British Columbia.